Jian-min Wang

He Huang, Xiao-jun Huang, Jianda Hu, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study

Jun Yu Li, A. Howes, Xiao-jun Huang, 2018, Cancer medicine.

Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study

He Huang, Jiong Hu, Xiao-jun Huang, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Risk Factors for Graft-Versus-Host Disease After Transplantation of Hematopoietic Stem Cells from Unrelated Donors in the China Marrow Donor Program

He Huang, Xiao-jun Huang, Depei Wu, 2017, Annals of transplantation.

Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China

J. Chen, He Huang, Xiao-jun Huang, 2015, Tumor Biology.

The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology

He Huang, Lanping Xu, Xiao-jun Huang, 2018, Journal of Hematology & Oncology.

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

He Huang, Xiao-hui Zhang, Lanping Xu, 2021, Journal of Hematology & Oncology.

Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant

Shunqing Wang, Lanping Xu, Xiao-jun Huang, 2017, Journal of Hematology & Oncology.

Haploidentical hematopoietic cell transplantation for severe acquired aplastic anemia: a case-control study of post-transplant cyclophosphamide included regimen vs. anti-thymocyte globulin & colony-stimulating factor-based regimen

Shunqing Wang, Lanping Xu, Depei Wu, 2019, Science China Life Sciences.

Shunqing Wang, Lanping Xu, Xiao-jun Huang, 2019, Science China Life Sciences.

Haplo‐identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study

Shunqing Wang, Lanping Xu, Xiao-jun Huang, 2016, British journal of haematology.

Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study

Yan Liu, Hua Jiang, B. Jiang, 2017, Cancer Chemotherapy and Pharmacology.

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.

Ming-Yu Liu, Fei Li, D. Blaise, 2023, Heliyon.

Long-Term Safety of Dasatinib in Chinese Chronic Phase Chronic Myeloid Leukemia Patients with Imatinib-Resistance or -Intolerance: Results from a 6-Year Follow-up of a Multicenter Phase II Study

Q. Jiang, Xiao-jun Huang, Jie Jin, 2016 .

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina.

M. Baccarani, He Huang, Zhi-xiang Shen, 2015, Blood.

Big stride in gene therapy for hemophilia B in China

Dan-Tong Yang, Jian-min Wang, Jianmin Wang, 2023, Blood science.

Aclarubicin and Low-Dose Cytosine Arabinoside in Combination with Granulocyte Colony-Stimulating Factor in Treating Acute Myeloid Leukemia Patients with Relapsed or Refractory Disease and Myelodysplastic Syndrome: A Multicenter Study of 112 Chinese Patients

Junmin Li, Jie Jin, Depei Wu, 2005, International journal of hematology.